EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Epidemiology, Drug-Resistant Variants, and Therapeutic Implications of Hepatitis B Virus and Hepatitis D Virus Prevalence in Nigeria: A National Study

Oludare 'Sunbo Adewuyi iD, Muhammad Shakir Balogun iD, Hirono Otomaru, Alash'le Abimiku iD, Anthony Agbakizu Ahumibe, Elsie Ilori, Que Anh Luong iD, Nwando Mba, James Christopher Avong, John Olaide iD, Oyeladun Okunromade iD, Adama Ahmad und 11 weitere

Pathogens · 2025

DOI: 10.3390/pathogens14010101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Oludare 'Sunbo Adewuyi und 22 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan. Hauptthemen laut MEDLINE: Hepatitis B virus, Hepatitis Delta Virus, Hepatitis D, Hepatitis B. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan, Kakenhi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Information on circulating HBV (sub-)genotype, variants, and hepatitis D virus (HDV) coinfection, which vary by geographical area, is crucial for the efficient control and management of HBV. We investigated the genomic characteristics of HBV (with a prevalence of 8.1%) and the prevalence of HDV in Nigeria. We utilised 777 HBV-positive samples and epidemiological data from the two-stage sampled population-based, nationally representative Nigeria HIV/AIDS Indicator and Impact Survey conducted in 2018. We assessed 732 HBV DNA-extracted samples with detectable viral loads (VLs) for (sub-)genotypes and variants by whole-genome pre-amplification, nested PCR of the s-and pol-gene, and BigDye Terminator sequencing. We conducted HDV serology. In total, 19 out of the 36 + 1 states in Nigeria had a high prevalence of HBV (≥8%), with the highest prevalence (10.4%) in the north-central geopolitical zone. Up to 33.2% (95% CI 30.0–36.6) of the participants had detectable VLs of ≥300 copies/mL. The predominant circulating HBV genotype was E with 98.4% (95% CI 97.1–99.1), followed by A with 1.6% (95% CI 0.9–2.9). Drug-resistant associated variants and immune escape variants were detected in 9.3% and 0.4%, respectively. The seroprevalence of HDV was 7.34% (95% CI 5.5–9.2). Nigeria has subtype E as the major genotype with many variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusHepatitis Delta VirusHepatitis DHepatitis BDrug Resistance, ViralHumansNigeriaPrevalenceMaleFemaleAdultMolecular EpidemiologyGenotypeMiddle AgedCoinfectionYoung AdultAdolescentViral LoadDNA, ViralAntiviral AgentsChildAged

Stichwörter der Autor:innen

HBVHDVNigeriadrug-resistant associated variantsgenotypesviral load

Substanzen

DNA, ViralAntiviral Agents

Autor:innen und Institutionen

  • Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.
  • Department of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
  • Nigeria Centre for Disease Control and Prevention, Abuja 240102, Nigeria.
  • Nigeria Field Epidemiology and Laboratory Training Programme, Abuja 900231, Nigeria.
  • African Field Epidemiology Network, Asokoro, Abuja 900231, Nigeria.
  • Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

ORCID-Profile: Oludare 'Sunbo Adewuyi, Muhammad Shakir Balogun, Alash'le Abimiku, Que Anh Luong, John Olaide, Oyeladun Okunromade, Chinwe Lucia Ochu, Haruka Abe, Michiko Toizumi, Hiroyuki Moriuchi, Lay-Myint Yoshida

Förderung

  • Japan Society for the Promotion of Science, Japan
  • Kakenhi

Zitieren

APA

Adewuyi, O., Balogun, M. S., Otomaru, H., Abimiku, A., Ahumibe, A. A., Ilori, E., Luong, Q. A., Mba, N., Avong, J. C., Olaide, J., Okunromade, O., Ahmad, A., Akinpelu, A., Ochu, C. L., Olajumoke, B., Abe, H., Ihekweazu, C., Ifedayo, A., Toizumi, M., …, & Yoshida, L. M. (2025). Molecular Epidemiology, Drug-Resistant Variants, and Therapeutic Implications of Hepatitis B Virus and Hepatitis D Virus Prevalence in Nigeria: A National Study. Pathogens. https://doi.org/10.3390/pathogens14010101

Vancouver

Adewuyi O, Balogun MS, Otomaru H, Abimiku A, Ahumibe AA, Ilori E, et al. Molecular Epidemiology, Drug-Resistant Variants, and Therapeutic Implications of Hepatitis B Virus and Hepatitis D Virus Prevalence in Nigeria: A National Study. Pathogens. 2025. doi:10.3390/pathogens14010101

BibTeX
@article{Adewuyi2025,
  author = {Adewuyi, Oludare 'Sunbo and Balogun, Muhammad Shakir and Otomaru, Hirono and Abimiku, Alash'le and Ahumibe, Anthony Agbakizu and Ilori, Elsie and Luong, Que Anh and Mba, Nwando and Avong, James Christopher and Olaide, John and Okunromade, Oyeladun and Ahmad, Adama and Akinpelu, Afolabi and Ochu, Chinwe Lucia and Olajumoke, Babatunde and Abe, Haruka and Ihekweazu, Chikwe and Ifedayo, Adetifa and Toizumi, Michiko and Moriuchi, Hiroyuki and Yanagihara, Katsunori and Idris, Jide and Yoshida, Lay-Myint},
  title = {Molecular Epidemiology, Drug-Resistant Variants, and Therapeutic Implications of Hepatitis B Virus and Hepatitis D Virus Prevalence in Nigeria: A National Study},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14010101}
}
Kostenlos starten →